His career has been focused on impacting diabetes care through innovative models, informed by his team’s research findings and using his leadership roles, to enable broad scale implementation. His journey to improve quality has traversed many arenas including better patient communication tools (motivational interviewing), creating the first broad scale diabetes registry, designing and implementing a care management training program leading on statewide implementation of the Patient Centered Medical Home across 150 practices, defining the medical neighborhood and the role of centers of excellence. Some highlights of these initiatives include founding the Penn State Institute for Diabetes and Obesity and statewide primary care transformation in Pennsylvania and establishing a national and international voice for new models of care at the ADA, Endocrine Society, and International Diabetes Federation.
Dr. Gabbay’s recruitment to the Joslin in 2013 provided an opportunity to implement, train, and lead care transformation utilizing his research findings to impact care locally, regionally, nationally and internationally. This has included guiding transformation of the Joslin affiliate program to become a broader population health partnership and implementation of core principles from his research in projects globally.
Dr. Gabbay’s research has been supported by the National Institute of Health, the Agency for Healthcare Research and Quality, and the Center for Medicare and Medicaid innovation. He has been invited to speak on numerous topics related to diabetes and is a Senior Editor of Diabetes Technology and Therapeutics, Editor-in-Chief of Evidence-Based Diabetes Management and serves on the Editorial Board of Diabetes Forecast. He has published extensively on better approaches to manage people with diabetes.
Dr. Gabbay holds B.Sc. degree in Biochemistry from McGill University, PhD in Biochemistry from University of Wisconsin and MD from State University of New York (SUNY) Health Sciences Center at Brooklyn. He completed his residency at New York Hospital – Cornell University Medical Center and fellowship in Endocrinology, Diabetes and Metabolism at a combined Harvard Medical School program that included Joslin Diabetes Center, Beth Israel Deaconess Medical Center, and Brigham and Women’s Hospital.